A new study from Johns Hopkins Medicine has revealed an exciting discovery that could change how we treat obesity.
Researchers found that a drug first designed for other serious conditions, including Alzheimer’s disease, schizophrenia, and sickle cell disease, may also help people lose weight and improve their overall health.
What makes this finding especially interesting is that the drug seemed to work without requiring changes to diet or exercise.
Obesity is a major health problem around the world. It increases the risk of many serious diseases, such as heart disease, type 2 diabetes, and liver problems. For many people, losing weight is very difficult, even with strict diets and regular exercise.
While some medications exist, there is still no simple and widely effective pill for treating severe obesity. Because of this, scientists have been searching for new ways to help people manage their weight and reduce health risks.
In this study, the researchers focused on a specific enzyme in the body called PDE9. Enzymes are proteins that help control many processes in our cells. PDE9 affects a molecule known as cyclic GMP, which plays an important role in how cells communicate and function.
This enzyme is related to another one called PDE5, which is targeted by well-known drugs like Viagra. Scientists already know that these types of enzymes can influence blood flow and heart function.
The drug used in this research is known as a PDE9 inhibitor. This means it blocks the activity of the PDE9 enzyme. Although PDE9 inhibitors are still experimental and do not yet have a commercial name, they have been studied for several conditions, including Alzheimer’s disease and heart failure.
In earlier research published in 2015, the same team found that PDE9 is present in the heart and may contribute to heart disease caused by high blood pressure.
Building on this earlier work, the researchers wanted to see whether blocking PDE9 could also help with problems linked to obesity. These problems include high blood pressure, high blood sugar, high cholesterol, and fatty liver disease. Together, these conditions are often called metabolic syndrome, which greatly increases the risk of serious illness.
To test their idea, the scientists carried out experiments using mice. They used a PDE9 inhibitor developed by Pfizer, called PF-04447943. This drug was originally created to treat Alzheimer’s disease, but it was later abandoned for that purpose.
However, it had already been tested in more than 100 people and was found to be safe, with no major side effects reported.
The results of the study were very encouraging. The mice that received the drug showed clear improvements in their body weight, liver health, and heart function. They had less fat in their livers and better heart performance. Importantly, these benefits happened without any changes to what the mice ate or how active they were.
If similar results are seen in humans, the impact could be very large. The researchers suggested that a person weighing around 250 pounds could potentially lose about 50 pounds with this treatment. This kind of weight loss could greatly reduce the risk of serious diseases and improve quality of life.
The benefits of the drug may go beyond weight loss. By improving heart health and reducing fatty liver, it could help treat several conditions at once. This makes it a promising option for people who struggle with multiple health problems linked to obesity.
Obesity is becoming more common, especially in countries like the United States. More than 40 percent of adults are now considered obese, and the rate is even higher among older women. These numbers show how urgent it is to find better treatments that are both safe and effective.
Although more research is needed, especially in human trials, this study offers strong hope. Another PDE9 inhibitor is already being tested in clinical trials for heart failure, which supports the idea that this type of drug could be useful in many areas of health.
The study was led by Dr. David Kass and was published in the Journal of Clinical Investigation. It opens the door to a new way of treating obesity and related diseases, and it may one day help millions of people live healthier lives.
If you care about weight loss, please read studies about orange that could help obesity, and a berry that can prevent cancer, diabetes and obesity.
For more health information, please see recent studies about ginger’s journey in weight management ,and green tea: a cup of weight loss.
Copyright © 2026 Knowridge Science Report. All rights reserved.
